What Scalpe Treats: Main Uses and Benefits

Treatments for common chronic scalp conditions are focused on managing inflammation and fungal involvement.

This preparation is primarily used for the symptomatic management of Seborrheic Dermatitis (SD) and common, recurrent dandruff (Pityriasis capitis). It is relevant for easing symptoms associated with Malassezia yeast overgrowth and accelerated epidermal cell production. The core therapeutic benefit is relevant for easing symptoms that interfere with daily functioning, particularly excessive scaling, visible flaking, and persistent itchiness.

Supporting Symptomatic Periods and Recurrence Control

This combination is applied in settings where symptoms become temporarily overwhelming, particularly in conditions involving episodic or fluctuating manifestations. It provides supportive relief that helps ease the overall symptom burden and may assist with maintaining functional stability during symptomatic phases. The preparation may assist with managing symptoms that create noticeable physiological strain and discomfort.

---

Quick Fact: Support for Flaking, Scaling, and Irritation

Focus Area	Symptomatic Benefit
Main Indications	Seborrheic Dermatitis, Recurrent Dandruff
Symptom Relief	Flaking, Scaling, Itching
Clinical Context	Chronic maintenance, Episodic flare-up support

Scalpe, a medicated shampoo containing Ketoconazole and Zinc Pyrithione (ZPTO), is primarily used for the treatment of dandruff and seborrheic dermatitis of the scalp in adults.

Contraindications (Who Cannot Use)

Scalpe should not be used by individuals with a known hypersensitivity or allergy to Ketoconazole, Zinc Pyrithione, or any of the inactive ingredients present in the shampoo. Symptoms of an allergic reaction may include severe irritation, redness, or swelling in the area of application.

Special Populations and Considerations

Population	General Guidance
Children	Use in infants and children (typically under 12 or 16 years of age, depending on the specific formulation) is generally not recommended unless explicitly advised and supervised by a pediatrician.
Pregnancy	While there is limited data on topical use, the shampoo should be used during pregnancy only if clearly necessary and the potential benefit outweighs the potential risk to the fetus. Consultation with a healthcare provider is essential.
Breastfeeding	Although Ketoconazole is generally not detectable in the plasma after topical application to the scalp, caution should be exercised. Consult a doctor before using Scalpe while breastfeeding.

Discontinue use immediately if a reaction suggesting sensitivity or irritation occurs. Avoid contact with the eyes.

Interactions with other medicines and products

The official interaction profile for Scalpe, a topical shampoo containing Ketoconazole and Pyrithione Zinc, is defined by its method of use: application to the scalp followed by rinsing. This route results in negligible systemic absorption of the active ingredients, a finding consistently reported in government regulatory documents.

Formal drug-drug interaction studies with the topical shampoo formulation are generally not conducted due to the minimal systemic exposure. Consequently, the extensive and complex systemic interaction profile associated with oral Ketoconazole is not applicable to this topical product.

Official Regulatory Findings

Category	Regulatory Status for Topical Formulation
Documented Interactions	None documented.
Contraindicated Combinations	None documented.
Metabolic (CYP) Interactions	None documented, as the active ingredients are typically not detected in plasma.
Timing-Separation Rules	None documented.
Food/Alcohol Interactions	None documented.

Connection to the overall interaction profile: The regulatory structure for this product confirms that due to its lack of systemic exposure, official labeling does not specify any interacting medicinal products, prohibited combinations, or mandatory administration timing requirements.

How Scalpe Works: Mechanism of Action

Targeting the Fungal Cell's Foundation: Ergosterol Synthesis Inhibition

Scalpe's primary action involves interrupting a fundamental synthesis process of the Malassezia yeast cell. The active ingredient, Ketoconazole, acts as an enzyme inhibitor, specifically targeting and blocking the production of ergosterol. Ketoconazole achieves this by inhibiting lanosterol 14-alpha demethylase (CYP51A1). This targeted molecular action destabilizes the yeast cell membrane, leading to its elimination and limiting the fungal population.

Dual-Action Microbial Control and Metabolic Disruption

The formula includes Zinc Pyrithione (ZPTO), which provides a complementary mechanism by disrupting fungal membrane transport systems and inhibiting vital metabolic processes. This dual approach—combining specific enzyme inhibition with broader metabolic interference—ensures comprehensive microbial population reduction, contributing to persistent control of Malassezia proliferation.

Breaking the Inflammation-Cell Turnover Cycle

The resulting decrease in the yeast bioburden on the scalp directly reduces the microbial metabolites that initiate the local inflammatory cascade. By controlling this microbial stimulus, the drug indirectly modulates the scalp's local physiological response. This allows the hyper-proliferative skin cell turnover to normalize, which results in a regulated state of epithelial cell production and shedding.

How to Use Scalpe: Official Administration Guidelines

This section outlines the standardized protocol for the administration of the Ketoconazole and Pyrithione Zinc combination shampoo. The product is exclusively intended for topical application to the scalp and affected skin area.

---

Administration Protocol

The usage of the preparation is structured into two distinct phases defined by frequency and duration. For the initial treatment phase of conditions such as seborrhoeic dermatitis or dandruff, the shampoo is applied twice weekly for a duration typically ranging from two to four weeks. Following this initial course, long-term use shifts to a less frequent maintenance phase (prophylaxis), where the product is applied once every one to two weeks.

---

Procedural and Contextual Requirements

Administration requires specific procedural steps. The container must be shaken well before use to ensure the proper suspension of the active ingredients. After application to wet hair and scalp, the shampoo must be left in contact with the skin for a mandated period of 3 to 5 minutes prior to being rinsed thoroughly with water.

These guidelines primarily apply to adults and adolescents, as specific usage data for children under 12 years of age is generally absent from the official labeling. A crucial high-level instruction mandates that individuals who have been receiving prolonged topical corticosteroid therapy should have this treatment gradually withdrawn over a period of two to three weeks when initiating the shampoo to manage the transition.

Research Evidence / Overview of Studies for Scalpe

This section summarizes the context of the available research on Scalpe's active ingredients and how studies have explored them, while acknowledging the limitations and uncertainties that currently exist in the evidence.

---

Evidence for use in Seborrheic Dermatitis of the Scalp

Published research exploring the condition of seborrheic dermatitis (SD) has primarily used short-term Randomized Controlled Trials (RCTs) and comparative studies. These studies were designed to evaluate symptom patterns in populations consisting mainly of adults studied for moderate to severe SD. Researchers used various clinical severity scores to measure outcomes related to physical discomfort, such as scaling, redness, and the overall appearance of the scalp.

Trials documented measurements of clinical scores over the treatment intervals (typically 2 to 4 weeks). Studies also monitored microbiological outcomes by examining Malassezia species population levels on the scalp. These research findings contribute to the broader evidence landscape for understanding how symptoms were measured during short-term intervention periods.

---

Evidence for use in Recurrent Dandruff (Pityriasis Capitis)

The evidence base for recurrent dandruff (Pityriasis Capitis) includes short-term placebo-controlled trials and comparative research. These studies were designed to evaluate outcomes related to symptom intensity, such as measurements of visible flaking, and patient-reported outcomes for discomfort, like itching and irritation.

Research was conducted during periods of increased symptom activity, primarily involving otherwise healthy adults with moderate to severe dandruff. Trials reported measurements of symptoms in the observed populations during the defined treatment time intervals, with data showing patterns related to symptom scores and microbiological levels.

---

What is Still Uncertain About Scalpe (Research Gaps)

The majority of published research was conducted on adults with moderate to severe symptoms of the targeted conditions; the results apply only to the populations studied. There is limited information for long-term outcomes that would provide comprehensive insight into maintenance regimens over many months or years. Furthermore, comparative evidence is lacking for the specific combination product over extended periods, an area where more research remains necessary.

Key Studies & References

1. Overview: Seborrheic dermatitis (General condition and chronicity information)

How to Store and Dispose of Scalpe?

The storage and disposal of this medicated shampoo must strictly follow official regulatory mandates to maintain its stability and ensure safety.

Official Storage Conditions

Requirement	Official Labeled Mandate
Temperature	Store at controlled room temperature (20^circC to 25^circC) or below 30^circC.
Protection	Protect from freezing and protect from light and moisture.
Packaging	Keep the container tightly closed and store in the original container.

Safety and Disposal

Keep out of the reach and sight of children at all times. Do not use the product after the expiration date. Unused or expired shampoo must not be poured down a drain or toilet; disposal must adhere to local pharmaceutical waste collection requirements to protect the environment.